DUBLIN, April 14, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/36zd5z/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market Report" report to their offering. 
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The analysts forecast the Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 16.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of sleep apnea. The Global Sleep Apnea Diagnostic and Therapeutic Devices market has also been witnessing an increase in the adoption of home diagnostic devices. However, the lack of patient compliance could pose a challenge to the growth of this market. 

The report, the Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2012- 2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the Global Sleep Apnea Diagnostic and Therapeutic Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

There has been an increase in the adoption of home sleep testing devices due to the increasing inclination of patients to be tested at home for convenience reasons and to prevent the patients from experiencing the unfamiliar environment of a sleep lab for sleep apnea diagnosis. Home diagnostics devices provide accurate results for people suffering from moderate-to-severe apnea. Home testing is also considered less obtrusive as it allows the test to be done in familiar surroundings and in the patient's own bed. 

It is also more advantageous to the home-bound, aged, those suffering from a chronic illness, and those who require specialized care by a family member. In addition, the home testing devices for sleep apnea are also cost-effective when compared with the cost of an in-lab sleep study. Therefore, this emerging trend can have a positive impact on the growth of the market.

According to the report, one of the main drivers of this market is the high prevalence of sleep apnea disorders across the globe in adults and children, and the associated conditions such as hypertension, stroke, Type II diabetes or adult onset diabetes, weight gain, impotence, and cardiovascular diseases.

Further, the report states that one of the major challenges faced by the market is the lack of patient compliance with sleep apnea diagnostic and therapeutic devices. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia, nasal stuffiness contributes to patient non-compliance when using CPAP or Bi-level PAP devices.

Key Topics Covered: 

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

5. Scope of the Report

6. Market Landscape

7. Geographical Segmentation

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

15. Other Reports in this Series


Companies Mentioned:

• Apnex Medical Inc.
• Cadwell Laboratories Inc.
• CareFusion Corp.
• Compumedics Ltd.
• Fisher & Paykel Healthcare Corp. Ltd.
• GE Healthcare Ltd.
• ImThera Medical Inc.
• Natus Medical Inc.
• Nihon Kohden Corp.
• Phillips Healthcare
• ResMed Inc.
• Ventus Medical Inc.
• Weinmann Gerate fur Medizin GmbH + Co. KG.

For more information visit http://www.researchandmarkets.com/research/36zd5z/global_sleep

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets